The effects of methylphenidate on weight, height, and body mass index in Turkish children and adolescents with ADHD

被引:3
|
作者
Turan, Serkan [1 ]
PEKCANLAR Akay, Aynur [2 ]
机构
[1] Odemis State Hosp, Dept Child & Adolescent Psychiat, TR-35750 Izmir, Turkey
[2] Dokuz Eylul Univ, Dept Child & Adolescent Psychiat, Med Fac, Izmir, Turkey
来源
ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY | 2020年 / 21卷 / 02期
关键词
methylphenidate; attention-deficit hyperactivity disorder; height; weight; BMI; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GROWTH; ASSOCIATION;
D O I
10.5455/apd.51135
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The pathophysiological mechanisms underlying the effects of psychostimulants (methylphenidate) treatment on growth still remain controversial. We examined the long term effects of methylphenidate on height, weight and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder (ADHD). Methods: Participants (6-18 years, 330 boys, 103 girls) diagnosed with ADHD who received treatment with methylphenidate for at least 1 year at the Department of Child and Adolescent Psychiatry at Dokuz Eylul University Medical School were included in a retrospective study. Weight, height, and BMI z scores were converted to age- and gender-corrected z scores using norms from the Turkish population at baseline and last follow-up. Results: Height and weight standard deviation score (SDS) were reduced by treatment (baseline height-SDS (SDS]: 0.74 +/- 1.43, followup height-SDS [SDS]: -0.67 +/- 4.35, t-test p<0.001; baseline weight SDS [SDS]: 0.61 +/- 1.28, and follow-up weight-SDS [SDS]: -0.41 +/- 0.76, t-test p<0.001). There were no differences in BMI-SDS before and after stimulant treatment (baseline BMI-SDS [SDS]: 0.27 +/- 1.21, follow-up BMI-SDS [SDS]: -0.20 +/- 4.54, t-test p=0.353). However, considering whether patients were children (6-12 years) or adolescents (13-18 years) when they started medication, in the group of children, height and BMI was affected by treatment (baseline height-SDS [SDS]: 0.87 +/- 1.42; follow-up height-SDS [SDS]: -0.78 +/- 4.81]; p=0.002; baseline BMI-SDS [SDS]: 0.29 +/- 1.19; follow-up BMI-SDS [SDS]: -0.21 +/- 0.69; p<0.001). Results of multiple linear regression analysis which assess the possible contribution of the different treatment-related factors, only age starting treatment (B=-0.039, p=0.011) predicted final weight. Conclusions: We conclude that methylphenidate shows a negative effect on height and BMI in children. It was thought that the findings obtained at the end of the study might be helpful in assessing the growth parameters that may facilitate the course of the ADHD, and in the improvement of more efficient and permanent treatment approaches, and the adherence of patients to the treatment.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 50 条
  • [41] Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder
    Pliszka, SR
    Matthews, TL
    Braslow, KJ
    Watson, MA
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (05) : 520 - 526
  • [42] Height and body mass index distribution in children and adolescents with and without spina bifida
    Bertapelli, Fabio
    de Baptista, Cyntia Rogean de Jesus Alves
    Mattiello-Sverzut, Ana Claudia
    JORNAL DE PEDIATRIA, 2024, 100 (01) : 46 - 52
  • [43] Change in reference body mass index percentiles and deviation in overweight and obesity over 3 years in Turkish children and adolescents
    Senol, Vesile
    Unalan, Demet
    Bayat, Meral
    Mazicioglu, M. Mumtaz
    Ozturk, Ahmet
    Kurtoglu, Selim
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2014, 27 (11-12) : 1121 - 1129
  • [44] Association Between Atopic Dermatitis and Height, Body Mass Index, and Weight in Children
    Nicholas, Mathew N.
    Keown-Stoneman, Charles D. G.
    Maguire, Jonathon L.
    Drucker, Aaron M.
    JAMA DERMATOLOGY, 2022, 158 (01) : 26 - 32
  • [45] Predictors of Methylphenidate response in children and adolescents with ADHD: the role of sleep disturbances
    D'Aiello, Barbara
    Menghini, Deny
    Di Vara, Silvia
    De Rossi, Pietro
    Vicari, Stefano
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2024,
  • [46] Effects of Atomoxetine on Height and Weight in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review
    Kweon, Kukju
    Yoon, Je Sik
    Park, Kee Jeong
    Kim, Seon-Ok
    Choi, Jin-Ho
    Kim, Hyo-Won
    PSYCHIATRY INVESTIGATION, 2018, 15 (06) : 649 - 654
  • [47] Growth references for weight, height, and body mass index for Ecuadorian children and adolescents aged 5-19 years
    Tarupi, Wilmer
    Lepage, Yvan
    Felix, Maria L.
    Monnier, Claude
    Hauspie, Roland
    Roelants, Mathieu
    Hidalgo, Ricardo
    Vercauteren, Martine
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2020, 118 (02): : 117 - +
  • [48] Body Mass Index Categories and Attained Height in Portuguese Adults
    Rosario, Rafaela
    Barros, Renata
    Padrao, Patricia
    Santos, Rute
    Teixeira, Vitor Hugo
    Lopes, Oscar
    Andrade, Nelson
    Moreira, Andre
    Moreira, Pedro
    OBESITY FACTS, 2018, 11 (04) : 287 - 293
  • [49] Socioeconomic differentials in misclassification of height, weight and body mass index based on questionnaire data
    Bostrom, G
    Diderichsen, F
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 (04) : 860 - 866
  • [50] Stress exposure in specific growth periods associates with children's weight, height, and body mass index
    Rodrigues, Daniela
    Machado-Rodrigues, Aristides M.
    Nogueira, Helena
    Gama, Augusta
    Silva, Maria-Raquel G.
    Bogin, Barry
    Padez, Cristina
    AMERICAN JOURNAL OF BIOLOGICAL ANTHROPOLOGY, 2023, 181 (04): : 588 - 596